$HCMC
Healthier Choices Management Corp.

2023 Q3 Form 10-Q Financial Statement

#000084485623000028 Filed on July 24, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $12.70M $13.57M
YoY Change 119.93% 121.38%
Cost Of Revenue $8.062M $8.493M
YoY Change 106.21% 123.44%
Gross Profit $4.643M $5.082M
YoY Change 148.65% 118.02%
Gross Profit Margin 36.54% 37.43%
Selling, General & Admin $8.034M $8.261M
YoY Change 101.58% 123.32%
% of Gross Profit 173.04% 162.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $137.3K $374.0K
YoY Change 111.31% 487.58%
% of Gross Profit 2.96% 7.36%
Operating Expenses $8.034M $8.261M
YoY Change 101.58% 123.32%
Operating Profit -$3.391M -$3.180M
YoY Change 60.09% 132.36%
Interest Expense $36.57K $97.31K
YoY Change -5.97% 482.35%
% of Operating Profit
Other Income/Expense, Net $400.2K $429.6K
YoY Change 825.9% 1777.21%
Pretax Income -$2.991M -$2.653M
YoY Change 44.14% 97.16%
Income Tax
% Of Pretax Income
Net Earnings -$2.991M -$2.744M
YoY Change 44.14% 103.96%
Net Earnings / Revenue -23.54% -20.22%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 463.3B 463.3B
Diluted Shares Outstanding 358.2B shares 353.9B

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.140M $8.483M
YoY Change -76.21% -56.16%
Cash & Equivalents $7.766M $8.482M
Short-Term Investments $1.710K $1.370K
Other Short-Term Assets $398.9K $2.460M
YoY Change -90.25% 907.35%
Inventory $3.554M $3.765M
Prepaid Expenses
Receivables $130.9K $92.65K
Other Receivables $0.00 $156.3K
Total Short-Term Assets $13.60M $14.96M
YoY Change -60.13% -32.89%
LONG-TERM ASSETS
Property, Plant & Equipment $2.865M $13.61M
YoY Change 87.49% 775.43%
Goodwill $5.747M $5.747M
YoY Change 116.3% 116.3%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $510.9K $481.4K
YoY Change -95.51% 303.28%
Total Long-Term Assets $23.50M $24.38M
YoY Change 106.72% 111.22%
TOTAL ASSETS
Total Short-Term Assets $13.60M $14.96M
Total Long-Term Assets $23.50M $24.38M
Total Assets $37.10M $39.34M
YoY Change -18.41% 16.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.804M $5.133M
YoY Change 81.19% 136.44%
Accrued Expenses $2.324M $1.966M
YoY Change 334.8% 249.0%
Deferred Revenue $144.9K $147.5K
YoY Change 152.89% 162.84%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $560.3K $1.005M
YoY Change 23.23% 120.75%
Total Short-Term Liabilities $9.286M $8.624M
YoY Change 118.51% 165.69%
LONG-TERM LIABILITIES
Long-Term Debt $1.955M $2.098M
YoY Change
Other Long-Term Liabilities $7.500M $8.395M
YoY Change 93.01% 109.04%
Total Long-Term Liabilities $1.955M $10.49M
YoY Change -49.69% 161.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.286M $8.624M
Total Long-Term Liabilities $1.955M $10.49M
Total Liabilities $18.74M $19.12M
YoY Change 130.36% 163.25%
SHAREHOLDERS EQUITY
Retained Earnings -$51.16M -$48.17M
YoY Change 24.38% 23.33%
Common Stock $47.53M $46.33M
YoY Change 39.89% 36.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $16.41M $20.22M
YoY Change
Total Liabilities & Shareholders Equity $37.10M $39.34M
YoY Change -18.41% 16.28%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$2.991M -$2.744M
YoY Change 44.14% 103.96%
Depreciation, Depletion And Amortization $137.3K $374.0K
YoY Change 111.31% 487.58%
Cash From Operating Activities -$1.281M -$1.314M
YoY Change 59.07% 10.31%
INVESTING ACTIVITIES
Capital Expenditures $28.10K $21.78K
YoY Change -172.59% -125.37%
Acquisitions
YoY Change
Other Investing Activities $145.4K $16.61K
YoY Change 835.99% 24.42%
Cash From Investing Activities $117.3K -$5.170K
YoY Change -605.91% -92.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -180.4K -11.06M
YoY Change -101.41% 1702100.0%
NET CHANGE
Cash From Operating Activities -1.281M -1.314M
Cash From Investing Activities 117.3K -5.170K
Cash From Financing Activities -180.4K -11.06M
Net Change In Cash -1.344M -12.38M
YoY Change -111.19% 879.4%
FREE CASH FLOW
Cash From Operating Activities -$1.281M -$1.314M
Capital Expenditures $28.10K $21.78K
Free Cash Flow -$1.309M -$1.336M
YoY Change 70.77% 20.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
2097932
us-gaap Operating Expenses
OperatingExpenses
7026693
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
353854819196
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
20206024
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
18277440
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
189225
CY2023Q2 us-gaap Inventory Net
InventoryNet
3765070
CY2022Q4 us-gaap Inventory Net
InventoryNet
3817192
CY2023Q2 hcmc Prepaid Expense And Vendor Deposits Current
PrepaidExpenseAndVendorDepositsCurrent
826611
CY2022Q4 hcmc Prepaid Expense And Vendor Deposits Current
PrepaidExpenseAndVendorDepositsCurrent
322182
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
1371
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
9771
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5005511
CY2023Q2 us-gaap Assets
Assets
39338975
CY2022Q4 us-gaap Assets
Assets
55255030
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5133314
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5715234
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2228852
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8623904
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9907366
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8395274
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8041504
CY2023Q2 us-gaap Liabilities
Liabilities
19117110
CY2022Q4 us-gaap Liabilities
Liabilities
20326931
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Goodwill
Goodwill
5747000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
481426
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13574896
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6132060
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27134640
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1345515
us-gaap Net Income Loss
NetIncomeLoss
-4560056
us-gaap Depreciation And Amortization
DepreciationAndAmortization
747485
us-gaap Depreciation And Amortization
DepreciationAndAmortization
422078
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1063591
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
377216
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11180613
CY2023Q2 us-gaap Gross Profit
GrossProfit
5081683
CY2022Q2 us-gaap Gross Profit
GrossProfit
2330873
us-gaap Gross Profit
GrossProfit
9996074
us-gaap Gross Profit
GrossProfit
4303387
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
3699273
us-gaap Operating Expenses
OperatingExpenses
15158780
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
189138
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
5150000
us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
32928
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
213133
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-115099
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5336011
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
35196
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33911
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7172984
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24690124
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26496404
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9110147
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19323420
us-gaap Interest Paid Net
InterestPaidNet
87008
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1797667
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-3943
CY2022Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
1800
us-gaap Gain Loss On Investments
GainLossOnInvestments
5314
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
101248
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
526905
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2652755
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1345515
us-gaap Net Income Loss
NetIncomeLoss
-4560056
us-gaap Net Income Loss
NetIncomeLoss
-2663430
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
353854819196
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
347796604758
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
347796604758
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
26570227
us-gaap Net Income Loss
NetIncomeLoss
-4600000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
26570227
us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
27122
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
148027
us-gaap Interest Paid Net
InterestPaidNet
2910
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27134640
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11180613
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13574896
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6132060
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27134640
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11180613
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
55815
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
628232
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10634634
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
476196
CY2023Q2 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
1000
CY2023Q2 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
1900000
CY2023Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
1944425
CY2022Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
0
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19324774
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29045802
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-48173997
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43613941
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
18277440
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
20206024
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
39338975
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55255030
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
8261343
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3179660
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1368400
us-gaap Operating Income Loss
OperatingIncomeLoss
-5162706
us-gaap Gain Loss On Investments
GainLossOnInvestments
-8400
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
198900
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
339741632384
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
339741632384
CY2023Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
13496525
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2652755
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
14722
CY2022Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
14722075
us-gaap Net Income Loss
NetIncomeLoss
-4560056
CY2023Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1944
CY2023Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
1944425
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2021Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
0
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
29233657
us-gaap Net Income Loss
NetIncomeLoss
-2663430
hcmc Issuance Of Common Stock In Connection With Cashless Exercise Of Series Warrants
IssuanceOfCommonStockInConnectionWithCashlessExerciseOfSeriesWarrants
1585000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13574896
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3179660
us-gaap Operating Income Loss
OperatingIncomeLoss
-2723306
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36469
dei Entity Registrant Name
EntityRegistrantName
HEALTHIER CHOICES MANAGEMENT CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-1070932
dei Entity Address Address Line1
EntityAddressAddressLine1
3800 North 28Th Way
dei Entity Address City Or Town
EntityAddressCityOrTown
Hollywood
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33020
dei City Area Code
CityAreaCode
305
dei Local Phone Number
LocalPhoneNumber
600-5004
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
HCMC
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
463266632384
CY2023Q2 us-gaap Cash
Cash
8481915
CY2022Q4 us-gaap Cash
Cash
22911892
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
92649
CY2023Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
156297
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1004809
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1224171
CY2022Q4 us-gaap Goodwill
Goodwill
5747000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10604935
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
372000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
774900
CY2023Q2 us-gaap Loans Payable Current
LoansPayableCurrent
552001
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
536542
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
2378061
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
1000
CY2022Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
14722
CY2023Q2 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
14722
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
800
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
14722
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
14722075
CY2022Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
800000
CY2023Q2 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
800000
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
800000
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
800000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
463266632384
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
463266632384
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
339741632384
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
339741632384
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
46326663
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
33974163
CY2023Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
13496
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
18957723
CY2023Q2 hcmc Temporary Equity Convertible Preferred Stock Redeemed Shares
TemporaryEquityConvertiblePreferredStockRedeemedShares
10637
CY2023Q2 hcmc Temporary Equity Convertible Preferred Stock Redeemed Value
TemporaryEquityConvertiblePreferredStockRedeemedValue
10637100
CY2023Q2 us-gaap Convertible Preferred Stock Converted To Other Securities
ConvertiblePreferredStockConvertedToOtherSecurities
22222
CY2023Q2 us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
91500
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1126750
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
18277440
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
27915742
us-gaap Inventory Write Down
InventoryWriteDown
951373
us-gaap Inventory Write Down
InventoryWriteDown
73640
us-gaap Share Based Compensation
ShareBasedCompensation
1176750
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-402900
hcmc Increase Decrease In Prepaid Expense And Vendor Deposits
IncreaseDecreaseInPrepaidExpenseAndVendorDeposits
-212226
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-219362
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
0
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
5230
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
33941
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-197306
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
528247
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-51137
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-249700
hcmc Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
1002484
hcmc Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
340611
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3658415
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1870884
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
264670
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
1285
us-gaap Payments For Repurchase Of Redeemable Convertible Preferred Stock
PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock
152500
us-gaap Payments For Repurchase Of Redeemable Convertible Preferred Stock
PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock
0
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
11170428
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11806463
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-15579977
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
hcmc Issuance Of Common Stock In Connection With Cashless Exercise Of Series Warrants
IssuanceOfCommonStockInConnectionWithCashlessExerciseOfSeriesWarrants
0
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1093290
CY2023Q2 us-gaap Cash
Cash
8481915
CY2022Q2 us-gaap Cash
Cash
19323420
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
628232
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
0
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9110147
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19323420
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7224665
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2219154
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4253960
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4105933
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1279331
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
993025
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2974629
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3112908
CY2023Q2 us-gaap Depreciation
Depreciation
143746
CY2022Q2 us-gaap Depreciation
Depreciation
63656
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7224665
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2680333
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4544332
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
916858
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
838877
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
694457
CY2023Q2 hcmc Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
710603
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4544332
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
198606
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
23178
hcmc Contract With Customer Liability Issued
ContractWithCustomerLiabilityIssued
638501
CY2022 hcmc Contract With Customer Liability Issued
ContractWithCustomerLiabilityIssued
859383
hcmc Contract With Customer Liability Redeemed
ContractWithCustomerLiabilityRedeemed
635391
CY2022 hcmc Contract With Customer Liability Redeemed
ContractWithCustomerLiabilityRedeemed
628012
hcmc Contract With Customer Liability Breakage Recognized
ContractWithCustomerLiabilityBreakageRecognized
-54247
CY2022 hcmc Contract With Customer Liability Breakage Recognized
ContractWithCustomerLiabilityBreakageRecognized
-55943
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
147469
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
198606
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
2914603
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
552001
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
536542
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2097932
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2378061
CY2023Q1 hcmc Percentage Of Stated Value Of Preferred Stock Will Be Paid To Purchaser Upon Conversion
PercentageOfStatedValueOfPreferredStockWillBePaidToPurchaserUponConversion
0.10
CY2023Q1 hcmc Percentage Of Stated Value Of Preferred Stock Will Be Paid To Purchaser Upon Conversion
PercentageOfStatedValueOfPreferredStockWillBePaidToPurchaserUponConversion
0.10
CY2022Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
93781000000
CY2023Q2 us-gaap Cash
Cash
8500000
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000844856
dei Security Exchange Name
SecurityExchangeName
NONE
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1778232
CY2023Q2 us-gaap Assets Current
AssetsCurrent
14956954
CY2022Q4 us-gaap Assets Current
AssetsCurrent
30308480
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2974629
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3112908
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4544332
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
147469
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
198606
CY2023Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
453232
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
453232
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1965888
CY2023Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1944
CY2023Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
1944
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
14722
CY2022Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
14700000
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
800
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
800
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
800
us-gaap Operating Income Loss
OperatingIncomeLoss
-2723306
CY2023Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-425000
CY2022Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-402900
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4600
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6175
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9250
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23049
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
14910
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
31513
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22885
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
602650
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
59876
CY2023Q2 us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
91500
CY2022Q2 us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
0
us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
152500
us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
0
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2744255
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
0
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4712556
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
0
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
339741632384
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
339741632384
CY2023Q2 hcmc Temporary Equity Conversion Of Convertible Preferred Stock Shares
TemporaryEquityConversionOfConvertiblePreferredStockShares
915
CY2023Q2 hcmc Temporary Equity Conversion Of Convertible Preferred Stock Value
TemporaryEquityConversionOfConvertiblePreferredStockValue
915000
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
915000
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2023Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1944
CY2023Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
1944425
CY2022Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2022Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
0
CY2022Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2022Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
0
hcmc Temporary Equity Convertible Preferred Stock Redeemed Shares
TemporaryEquityConvertiblePreferredStockRedeemedShares
11193
hcmc Temporary Equity Convertible Preferred Stock Redeemed Value
TemporaryEquityConvertiblePreferredStockRedeemedValue
11192650
us-gaap Convertible Preferred Stock Converted To Other Securities
ConvertiblePreferredStockConvertedToOtherSecurities
22222
hcmc Temporary Equity Conversion Of Convertible Preferred Stock Shares
TemporaryEquityConversionOfConvertiblePreferredStockShares
1585
hcmc Temporary Equity Conversion Of Convertible Preferred Stock Value
TemporaryEquityConversionOfConvertiblePreferredStockValue
1585000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1585000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
152500
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1176750
CY2022Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
us-gaap Net Income Loss
NetIncomeLoss
-2663430
us-gaap Gain Loss On Investments
GainLossOnInvestments
-8400
us-gaap Gain Loss On Investments
GainLossOnInvestments
5314
us-gaap Share Based Compensation
ShareBasedCompensation
0
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
36834
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
2157
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
899251
hcmc Increase Decrease In Prepaid Expense And Vendor Deposits
IncreaseDecreaseInPrepaidExpenseAndVendorDeposits
670178
hcmc Payments For Deferred Offering Costs
PaymentsForDeferredOfferingCosts
218865
hcmc Payments For Deferred Offering Costs
PaymentsForDeferredOfferingCosts
0
hcmc Accrued Payment Of Induced Conversions Of Preferred Stock
AccruedPaymentOfInducedConversionsOfPreferredStock
22222
hcmc Accrued Payment Of Induced Conversions Of Preferred Stock
AccruedPaymentOfInducedConversionsOfPreferredStock
0
hcmc Non Cash Deferred Offering Cost
NonCashDeferredOfferingCost
384614
hcmc Non Cash Deferred Offering Cost
NonCashDeferredOfferingCost
0
CY2023Q2 us-gaap Cash
Cash
8500000
CY2023Q2 hcmc Working Capital Deficit
WorkingCapitalDeficit
6300000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Reclassification</span></div> <div><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Certain amounts in the condensed consolidated financial statements and related notes have been reclassified to conform to the current year presentation. Such reclassifications do not impact the Company’s previously reported financial position or net income (loss). $150,000 inventory shrink was originally presented in the statement of cash flow under change in operating assets inventory in cash used in operating activities for six months ended June 30, 2022, it was reclassified to <span style="-sec-ix-hidden:Fact_e3e3a10e63a2480fa55f6eb5b59c4c40">write-down of obsolete and slow-moving inventory</span> <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">under cash used in operating activities in the statement of cash flow.</span></div> <div><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">The </span>change in the fair value measurement on contingent consideration <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">was presented under Other (expense) income, net in the statement of operations for three months ended March 31, 2023. For the three months ended June 30, 2023, the Company presented the change in fair value remeasurement as a separate line in the statement of operations.</span></div>
hcmc Concentration Of Deposits Number Of Financial Institutions
ConcentrationOfDepositsNumberOfFinancialInstitutions
1
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2023Q2 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
7458162
CY2022Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
21682144
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6132060
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1368400
us-gaap Operating Income Loss
OperatingIncomeLoss
-5162706
us-gaap Depreciation
Depreciation
286306
us-gaap Depreciation
Depreciation
113592
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5005511
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
230277
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
165100
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
461179
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
308486
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
461179
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
922358
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
2649933
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1127000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
0
us-gaap Share Based Compensation
ShareBasedCompensation
1177000
us-gaap Share Based Compensation
ShareBasedCompensation
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
68837000000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
463266632384
us-gaap Net Income Loss
NetIncomeLoss
-2700000

Files In Submission

Name View Source Status
0000844856-23-000028-index-headers.html Edgar Link pending
0000844856-23-000028-index.html Edgar Link pending
0000844856-23-000028.txt Edgar Link pending
0000844856-23-000028-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
hcmc-20230630.xsd Edgar Link pending
image00001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
hcmc-20230630_cal.xml Edgar Link unprocessable
hcmc-20230630_def.xml Edgar Link unprocessable
hcmc-20230630_lab.xml Edgar Link unprocessable
hcmc-20230630_pre.xml Edgar Link unprocessable
form10q_htm.xml Edgar Link completed
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable